細胞番号 : 細胞名
RCB0762 : MT-9
update : 2022/03/23
|
| 細胞特性(Comment:英) | Rat cell line derived from malignant fibrous histiocytoma. Possessing characteristics of histiocytes. |
| 細胞特性(日) | ラット悪性線維性組織球腫由来細胞株。組織球の特性を有する。 |
| 細胞特性(寄託者記述:英) | |
| 細胞特性(寄託者記述:日) | |
| 使用条件(英) | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| 使用条件(日) | 基礎的研究につきましては、使用制限はありません。商業利用や特許取得を目的とする場合は、事前に必ず理研細胞バンクに連絡をすること。 |
| 備考(英) | |
| 備考(日) | |
| 提供申込書類(英) |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
| 提供申込書類(日) |
依頼書C-0001.pdf
同意書(非営利学術目的)C-0003.pdf
同意書(営利目的)C-0003p.pdf
|
|
提供同意書は、使用機関の種類や目的に応じて、非営利学術目的 (C-XXXX) と営利目的 (C-XXXXp) の2種類があります。該当する提供同意書をご使用ください（詳細）。特許等の取得及び商業利用等は事前に必ず cellbank.brc@riken.jp までご連絡ください。
|
| 提供手数料 |
手数料とお支払いについてはこちらをご覧ください。 |
|
細胞基本情報
|
|
寄託者 |
Yamate, Jyoji
|
| 樹立者 |
Yamate, Jyoji
|
| 寄託日 |
1992
|
| 元の細胞 |
MT-P
|
| 動物種 |
_rat
< Mammals
|
| 動物系統名 |
F344/DuCrj
|
| 属名 |
Rattus
|
| 種名 |
norvegicus
|
| 性別 |
Male
|
| 齢 |
15 months
|
| 採取組織 |
subcutis of the head
|
| 病名 |
Malignant Fibrous Histiocytoma
|
| 転移 |
No
|
| 細胞分類 |
cancer
|
| 初代培養日 |
1986
|
|
細胞寿命 |
infinite
|
| 細胞形態 |
fibroblast-like
|
| Cellosaurus(Expasy) |
CVCL_5338
|
|
細胞培養・検査情報
| |
寄託時情報 |
ロット情報 |
| 培地・試薬情報 |
培地・試薬一覧はこちらをご覧ください。 |
|
培養形態 |
|
Adherent cells
|
| 培地 |
|
DMEM (low glucose) + 10% FBS
|
| 抗生物質 |
|
Free
|
|
継代方法 |
|
0.25% Trypsin
|
|
継代密度 |
|
1 : 8 split
|
| 継代・培地交換頻度 |
|
Subculture : 2 times/week
|
| 培養最適温度 |
|
37
℃
|
| 二酸化炭素濃度 |
|
5
%
|
| 凍結培地 |
|
Medium + 10% DMSO
|
| 凍結方法 |
|
Slow freezing
|
| マイコプラズマ/アコレプラズマ |
|
(-)
|
| 動物種PCR |
|
OK
|
| アイソザイム検査 |
|
LD, NP
|
| 画像情報 |
寄託時情報 | ロット情報 |
|
|
|
| 文献情報 |
Reference(英) |
16件
|
| Reference(日) |
1件
|
| 利用者成果(英) |
0件
|
| 利用者成果(日) |
0件
|
| Reference(英) |
|
3495
Takashi Kotera 1 , Chisa Katou-Ichikawa, Anusha Hemamali Tennakoon, Miyuu Tanaka, Natsuki Tanaka, Takeshi Izawa, Mitsuru Kuwamura, Jyoji Yamate
Rat malignant fibrous histiocytoma (MFH)-derived cloned cell lines (MT-8 and MT-9) show different differentiation in mesenchymal stem cell lineage
Eep Toxicol Pathol
2015
67(10):499-507
PubMed ID: 26208870
DOI: 10.1016/j.etp.2015.07.004
|
|
3493
Ryo Yano, Hossain M Golbar, Takeshi Izawa, Osamu Sawamoto, Mitsuru Kuwamura , Jyoji Yamate
Participation of bone morphogenetic protein (BMP)-6 and osteopontin in cisplatin (CDDP)-induced rat renal fibrosis
Eep Toxicol Pathol
2015
67(2):99-107
PubMed ID: 25467747
DOI: 10.1016/j.etp.2014.10.002
|
|
3490
Takeshi Izawa, Takashi Horiuchi, Machi Atarashi, Mitsuru Kuwamura, Jyoji Yamate
Anti-fibrotic Role of miR-214 in Thioacetamide-induced Liver Cirrhosis in Rats
Toxicol Pathol
2015
43(6):844-51
PubMed ID: 25755099
DOI: 10.1177/0192623315573587
|
|
3494
Jyoji Yamate, Keiko Ogata, Takahiro Yuasa, Mitsuru Kuwamura, Shigeo Takenaka, Daijirou Kumagai, Kazuyuki Itoh, Jonathan LaMarre
Adipogenic, osteogenic and myofibrogenic differentiations of a rat malignant fibrous histiocytoma (MFH)-derived cell line, and a relationship of MFH cells with embryonal mesenchymal, perivascular and bone marrow stem cells
Eur J Cancer
2007
43(18):2747-56
PubMed ID: 18036812
DOI: 10.1016/j.ejca.2007.10.021
|
|
3491
Jyoji Yamate, Masanori Kuribayashi, Mitsuru Kuwamura, Takao Kotani, Kikumi Ogihara
Differential immunoexpressions of cytoskeletons in renal epithelial and interstitial cells in rat and canine fibrotic kidneys, and in kidney-related cell lines under fibrogenic stimuli
Eep Toxicol Pathol
2005
57(2):135-47.
PubMed ID: 16325524
DOI: 10.1016/j.etp.2005.07.001
|
|
2786
Tsunenari I, Yamate J, Iwaki M, Kuwamura M, Kotani T, Sakuma S
Angioarchitecture of tumors induced by two different cloned cell lines established from a transplantable rat malignant fibrous histiocytoma.
Microsc Microanal
2003
9:532-41
PubMed ID: 14750988
DOI: 10.1017/S1431927603030289
|
|
2788
Kumagai D, Yamate J, Tajima T, Tsukamoto Y, Yasui H, Kuwamura M, Kotani T, Sakuma S
Distribution of cells labelled by a monoclonal antibody (A3) against a cloned cell line derived from a rat malignant fibrous histiocytoma
J Comp Pathol
2001
123:77-87
PubMed ID: 11032659
DOI: 10.1053/jcpa.2000.0389
|
|
2783
Yamate J, Maeda M, Benn SJ, Laithwaite JE, Allan A, Ide M, Kuwamura M, Kotani T, Sakuma S, Lamarre J
Differential effects of transforming growth factor-beta1, a fibrogenic factor, on macrophage-like cells (HS-P) and myofibroblastic cells (MT-9) in vitro.
Toxicol Pathol
2001
29:483-91
PubMed ID: 11560254
DOI: 10.1080/01926230152500103
|
|
2784
Yamate J, Maeda M, Benn SJ, Laithwaite JE, Allan A, Ide M, Kuwamura M, Kotani T, Sakuma S, LaMarre J
Effects of lipopolysaccharide on a macrophage-like cell line (HS-P) from a rat histiocytic sarcoma.
J Comp Pathol
2001
125:15-24
PubMed ID: 11437512
DOI: 10.1053/jcpa.2001.0472
|
|
2787
Kumagai D, Yamate J, Tajima T, Kuwamura M, Kotani T, Sakuma S
Malignant fibrous histiocytoma (MFH) cells and macrophages/histiocytes have a common antigen recognized by a monoclonal antibody risen against a rat MFH-derived cloned cell line.
J Vet Med Sci
2001
63:333-5
PubMed ID: 11307938
DOI: 10.1292/jvms.63.333
|
|
2789
Tsunenari I, Yamate J, Sharma KD, Kawachi M, Sakuma S
Expressions of vascular endothelial growth factor and basic fibroblast growth factor in tumors induced by two different cloned cell lines established from transplantable rat malignant fibrous histiocytoma.
J Vet Med Sci
2000
62:699-705
PubMed ID: 10945286
DOI: 10.1292/jvms.62.699
|
|
2792
Yamate J, Tajima M, Shibuya K, Kuwamura M, Kotani T, Sakuma S, Takeya M
Heterogeneity in the origin and immunophenotypes of "histiocytic" cells in transplantable rat malignant fibrous histiocytoma.
J Vet Med Sci.
1996
58:603-609
PubMed ID: 8844594
DOI: 10.1292/jvms.58.603
|
|
2790
Yamate J, Tajima M, Shibuya K, Kuwamura M, Kotani T, Sakuma S
Phenotypic changes in lipopolysaccharide-treated cloned cells derived from transplantable rat malignant fibrous histiocytoma.
J Vet Med Sci
1996
58:1017-20
PubMed ID: 8916004
DOI: 10.1292/jvms.58.10_1017
|
|
2791
Yamate J, Tajima M, Shibuya K, Kuwamura M, Kotani T, Sakuma S
Phenotypic modulation in cisplatin-resistant cloned cells derived from transplantable rat malignant fibrous histiocytoma.
Pathol Int
1996
46:557-67
PubMed ID: 8893224
DOI: 10.1111/j.1440-1827.1996.tb03654.x
|
|
2793
Yamate J, Tajima M, Shibuya K, Saitoh T
Enhancement of lipid phagocytosis by cloned cells derived from rat malignant fibrous histiocytoma under hyperlipemic conditions.
Pathol Int
1994
44:735-44
PubMed ID: 7834074
DOI: 10.1111/j.1440-1827.1994.tb02920.x
|
|
1671
Yamate J, Tajima M, Togo M, Shibuya K, Ihara M, Kudow S
Heterogeneity of Cloned Cell Lines Established from a Transplantable Rat Malignamnt Fibrous Histiocytoma
Jpn J Cancer Res
1991
82:298-307
PubMed ID: 1850724
DOI: 10.1111/j.1349-7006.1991.tb01846.x
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト